From: Folate levels in hepatocellular carcinoma patients with portal vein thrombosis
PVT (n = 78) | NPVT (n = 60) | Controls (n = 70) | PVT versus NPVT(p value) | PVT versus Controls (p value) | NPVT versus Controls (p value) | |
---|---|---|---|---|---|---|
Bilirubin (mg/dl) | 2.87 ± 0.6 | 2.36 ± 1.02 | 1.24 ± 0.38 | < 0.001 | < 0.001 | < 0.001 |
Albumin (g/dl) | 3.15 ± 0.42 | 3.44 ± 0.38 | 3.96 ± 0.55 | < 0.001 | < 0.001 | < 0.001 |
INR | 2.91 ± 0.54 | 2.00 ± 0.57 | 1.22 ± 0.36 | < 0.001 | < 0.001 | < 0.001 |
Tot cholesterol (mmol/l) | 5.77 ± 1.08 | 5.69 ± 1.01 | 5.50 ± 1.04 | 0.659 | 0.124 | 0.297 |
HDL (mmol/l) | 1.40 ± 0.36 | 1.41 ± 0.37 | 1.46 ± 0.40 | 0.873 | 0.338 | 0.463 |
LDL (mmol/l) | 3.44 ± 0.38 | 3.48 ± 0.39 | 3.46 ± 0.37 | 0.545 | 0.747 | 0.765 |
Triglycerides (mmol/l) | 1.57 ± 0.70 | 1.50 ± 0.68 | 1.48 ± 0.65 | 0.556 | 0.421 | 0.864 |
ALT (IU/l) | 51.20 ± 10.80 | 48.20 ± 11.90 | 34.50 ± 10.20 | 0.124 | < 0.001 | < 0.001 |
AST (IU/l) | 49.20 ± 10.60 | 48.70 ± 10.80 | 33.10 ± 10.80 | 0.786 | < 0.001 | < 0.001 |
γGT (IU/l) | 82.80 ± 10.20 | 74.90 ± 12.10 | 27.40 ± 10.80 | < 0.001 | < 0.001 | < 0.001 |
AFP (mg/l) | 236.10 ± 15.80 | 240.20 ± 14.20 | 3.20 ± 0.60 | 0.117 | < 0.001 | < 0.001 |
Serum folate (nmol/l) | 5.24 ± 2.81 | 6.84 ± 2.71 | 8.50 ± 3.01 | < 0.001 | < 0.001 | 0.001 |
Red cell folate (nmol/l) | 144.20 ± 30.60 | 177.80 ± 28.20 | 294.20 ± 27.80 | < 0.001 | < 0.001 | < 0.001 |
Total homocysteine (μmol/l) | 32.80 ± 12.20 | 28.20 ± 13.10 | 10.70 ± 6.90 | 0.035 | < 0.001 | < 0.001 |